Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03261453 · ClinicalTrials.gov registry record · NA
THE Enlighten Study
A NA study, sponsored by Allurion Technologies.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
NCT03261453: Completed NA study, sponsored by Allurion Technologies.
NCT03261453 is a NA study that has completed, run by Allurion Technologies. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03261453, a NA study, has completed, sponsored by Allurion Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
Study Summary
The primary objective of this study is to demonstrate the safety and efficacy of the Elipse Gastric Balloon System for the treatment of obese adults.
Interventions
- DEVICE Active Elipse Device
- DEVICE Elipse Sham Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03261453
The ClinicalTrials.gov registry entry for NCT03261453 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Allurion Technologies, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Active Elipse Device is the first listed.
NCT03261453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03261453 about?
NCT03261453 is a clinical study titled "THE Enlighten Study". The primary objective of this study is to demonstrate the safety and efficacy of the Elipse Gastric Balloon System for the treatment of obese adults.
What is the current status of trial NCT03261453?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2018-02-01. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT03261453?
The interventions under investigation include: Active Elipse Device (DEVICE), Elipse Sham Device (DEVICE).
Who is sponsoring clinical trial NCT03261453?
This trial is sponsored by Allurion Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.